Senzime at the Innovation Pavilion

News: Uppsala, September 4, 2018. Senzime AB (publ) has been selected to exhibit at the Innovation Pavilion at The MedTech Conference in Philadelphia, Pennsylvania September 24-26. Fourteen innovative companies have been given this opportunity by AdvaMed.   

Lena Söderström appointed Biotech Builder 2018

News: Uppsala, August 29, 2018. Lena Söderström has been appointed Biotech Builder 2018 of the year. The award is appointed to Life Science entrepreneurs who have made significant progress in the course of time, while being an inspiration for others in the industry.

TetraGraph Exhibition and Poster presentation at The Euroanaesthesia 2018 Annual Meeting, Copenhagen, Denmark, June 2-4

News: Uppsala, June 8, 2018. 

TetraGraph Exhibition and Poster at The International Anesthesia Research Society’s (IARS) 2018 Annual Meeting, Chicago

News: Uppsala, May 4, 2018. 

TetraGraph Poster and Abstract presentation at The Society for Technology in Anesthesia (STA) 2018

News; Uppsala, January 19, 2018. The STA 2018 Annual Meeting in Turnberry Isle Miami Aventura, Florida, January 10-13, is designated for a national and international audience of physicians, engineers and industry members, as well as other practitioners in the field of anesthesia seeking an update on the current and future state of anesthesia technology. https://www.stahq.org/events/annual-meeting

Meet Senzime at Arab Health in Dubai, 29th January – 1st February

News; Uppsala, January 8, 2018.

Meet Senzime at WSM in London, 10-12 January

NEWS; Uppsala, January 5, 2018. For over 30 years the Winter Scientific Meeting (WSM) in London has been a great way for anaesthetists to develop their specialty knowledge and network with the wider anaesthesia community over three days. http://www.wsmlondon.org/

NEWS; Consensus Statement on Perioperative Use of Neuromuscular Monitoring

Uppsala, December 11, 2017.  A panel of clinician scientists with expertise in neuromuscular blockade (NMB) monitoring was convened with a charge to prepare a consensus statement on indications for, and proper use of, such monitors. This statement was published online at www.anesthesia-analgesia.org on November 30, 2017 (2018 in press), Copyright 2017 International Anesthesia Research Society.

Meet Senzime at Medica Trade Fair in Düsseldorf, 13-16 November

Uppsala, November 8, 2017. Medica Trade Fair in Düsseldorf is the world's leading trade fair for the medical industry. The fair consists of 17 halls where exhibitors from all over the world will present their products. Welcome to meet Senzime at Medica to learn more about our patient monitoring products OnZurf Probe, CliniSenz Analyzer and TetraGraph.

Senzime reports from the American Society of Anesthesiologists (ASA)

NEWS Uppsala, 26 October 2017. Senzime reports from the American Society of Anesthesiologists (ASA) Annual Meeting in Boston, USA. 

NEWS: Senzime reports from the Innovation Pavilion at The MedTech Conference

Uppsala, September 29, 2017. Senzime AB (publ) has been presenting the TetraGraph @ the Innovation Pavilion during The MedTech Conference in San José, California September 25-27. 

Senzime at the Innovation Pavilion

Uppsala, August 9, 2017. Senzime AB (publ) has been selected to exhibit at the Innovation Pavilion at The MedTech Conference in San José, California September 25-27. Ten innovative companies has been given this opportunity by AdvaMed.

Interesting days at the Euroanesthesia 2017 meeting

Uppsala, June 8, 2017. As previously announced, Senzime AB (publ) participated at the Euroanesthesia (ESA) 2017 meeting in Geneva Switzerland June 3-5. ESA is the leading European Organisation for Anaesthesia, Critical Care, Pain and Perioperative Medicine. 

Meet Senzime at Euroanesthesia 2017

Uppsala, May 24, 2017.  Senzime AB (publ) will be participating at Euroanaesthesia 2017 in Geneva, Switzerland June 3-5, 2017. 

Senzime receives research grants from Green Innovation Park

Uppsala, 19 May 2017. Senzime (publ) receives research grant from Green Innovation Park (GIP). This collaborative study is aimed at evaluating the usability of OnZurf Probe to monitor dispersion of various substances in soil. The study will be conducted at Swedish University of Agricultural Sciences (SLU) in Umeå, as a collaboration between Senzime and researchers in the Department of Forest Ecology and Care. The grant of 50,000 SEK allows the company to expand the market opportunities for OnZurf Probe to include ecologic monitoring.

Senzime participated at the International Anesthesia Research Society Annual meeting, IARS

Washington DC May 6-9, 2017

Senzime’s Annual Report 2016

Uppsala, April 28, 2017. Senzime AB’s (publ) annual report for fiscal year 2016 is now available on the company’s webbsite www.senzime.com.

Preliminary results to be presented at IARS 2017

Uppsala, March 13, 2017. Senzime AB (publ) is happy to announce that the abstract authored by Dr. J. Ross Renew from the Mayo Clinic and entitled, “Examining Awake Volunteer Pain Scores and Operator Ease of Use of a Novel Neuromuscular Blockade Monitor” was accepted for publication. The volunteer study compared the TetraGraph and TOF-Watch, and the results will be presented at IARS (International Anesthesia Research Society) 2017 Annual Meeting and International Science Symposium, in Washington DC, May 6-9.

Senzime AB (publ) launches new website

Senzime in the news- Needle-free probe provides information on how organs and tissues recover after surgery

Uppsala BIO and BIO-X writes about Senzime in their news. Senzime has developed an integrated monitoring system that can provide information on the state of a body’s organs. A probe (OnZurf Probe) placed on the tissue surface collects a microdialysis sample that is read by an instrument (CliniSenz Analyzer). Senzime is one of the companies that received funding in the BIO-X call ‘New diagnostic solutions for disease monitoring’.

Senzime introduces TetraGraph film

Uppsala, October 28, 2016. Senzime proudly presents a new film describing TetraGraph

Meet Senzime at Medica Trade Fair in Düsseldorf, 14-17 November

Senzime introduces new graphical profile

Uppsala, October 3, 2016. Senzime AB (publ.) changes graphic profile. Following the acquisition and integration of Acacia Designs BV, a new graphical profile is introduced to reflect the new Senzime - a company at the forefront of patient monitoring.

Senzime introduces new graphical profile

Uppsala, October 3, 2016. Senzime AB (publ.) changes graphic profile. Following the acquisition and integration of Acacia Designs BV, a new graphical profile is introduced to reflect the new Senzime - a company at the forefront of patient monitoring.

Preclinical results from OnZurf probe will be presented at clinical congresses

Uppsala, August 19, 2016. Results from preclinical studies with OnZurf probe will be presented at “Kirurgveckan” in Malmö/Lund and at “The International Society for Diseases of the Esophagus” in Singapore.

We are launching our new website!

Monitoring of ischemia with OnZurf Probe is accepted for scientific publication

Meet Senzime at the Swiss-Scandinavian Bio-Business Seminar

Senzime brings together the company's clinical monitoring of glucose and lactate under the same trademark - CliniSenz

Uppsala, Sweden, August 26 2015. Senzime have developed user-friendly products for continuous monitoring of glucose and lactate in complex biological fluids such as blood and cell cultures. These measurements are important – and in many cases critical - for patients undergoing surgeries and whom are at risk for unnecessary and dangerous complications if measurements are not managed correctly.  Senzime is now collecting the business’ offer for healthcare as one trade mark - CliniSenz.